From: Stated preferences for anti-malarial drug characteristics in Zomba, a malaria endemic area of Malawi
Model 1: Normally distributed coefficients (N=508 respondents, 3899 responses) | Model 2: Log-normally distributed coefficients (N=508 respondents, 3899 responses) | |||
---|---|---|---|---|
Variable | Estimate Coefficient [SD] | Standard error Coefficient [SD] | Estimate Coefficient [SD] | Standard error Coefficient [SD] |
Cost($) | −0.63 [0.52] | 0.05*** [0.06]*** | n/a | n/a |
Fever duration1 | −0.11 [0.03] | 0.01*** [0.03] | n/a | n/a |
Risk of rash | −1.27 [0.76] | 0.09*** [0.10]*** | n/a | n/a |
Savings($) (i.e. inverse of cost) | n/a | n/a | −0.76 [1.59] | 0.14*** [0.38]*** |
Days without fever (i.e. inverse of fever duration) | n/a | n/a | 0.015 [0.02] | 0.011 [0.02] |
Probability of no side effect (i.e. inverse of risk of rash) | n/a | n/a | 0.14 [0.90] | 0.09 [0.13]*** |
Official treatment | 3.06 [2.29] | 0.24*** [0.22]*** | 3.44 [2.42] | 0.32*** [0.32]*** |
Prophylaxis duration | 0.05 [0.04] | 0.004*** [0.005]*** | 0.06 [0.04] | 0.005*** [0.006]*** |
Course duration | −0.29 [0.06] | 0.05*** [0.11] | −0.32 [0.20] | 0.06*** [0.13] |
Relative variance: Urban vs. rural1 | 1.59 [0] | 0.37 | 1.43 [0] | 0.30 |
Relative variance: Peri-urban vs. rural1 | 0.91 [0] | 0.19 | 0.85 [0] | 0.19 |
−2 x(Mean simulated Log-likelihood ratio)2 | 47.4*** | 10.40 |